Skip to content
MarketScale
‹ Back to IndustriesSciences

Phononic + MarketScale Recap

Phononic, a solid-state cooling and heating solutions provider, has partnered with MarketScale to produce video content that showcases its technology. The collaboration leverages MarketScale's video production and community-generated content capabilities to engage and educate audiences about Phononic's innovations. Together, the two companies aim to tell compelling visual stories around Phononic's products and market impact.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

Promoted content from Phononic on MarketScale.

By Sciences ·
Share

Key takeaways

01

Phononic specializes in solid-state cooling and heating technology and partnered with MarketScale for content production.

02

The partnership focuses on video storytelling to educate and engage target audiences about Phononic's solutions.

03

MarketScale provides video production and community-generated content expertise to amplify Phononic's brand presence.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

Phononic, a leading provider of solid-state cooling and heating solutions, has formed a dynamic partnership with MarketScale, a renowned video production and community-generated content creation company. This collaboration brings together Phononic’s expertise in innovative technology and MarketScale’s prowess in visual storytelling, resulting in captivating video content that engages and educates audiences.

Through their partnership, Phononic and MarketScale combine their strengths to produce high-quality videos that showcase the transformative power of solid-state cooling and heating solutions across various industries. MarketScale’s talented team of videographers and content creators work closely with Phononic to craft compelling narratives that highlight the benefits, applications, and real-world impact of Phononic’s technology.

By leveraging MarketScale’s community-generated content creation capabilities, the partnership enables Phononic to gather valuable insights, experiences, and testimonials from users and industry experts. This collaborative approach ensures that the content resonates with the target audience and offers valuable perspectives on the practical applications of Phononic’s solutions.

Together, Phononic and MarketScale create visually stunning videos that not only showcase the technical aspects of solid-state cooling and heating but also demonstrate the positive outcomes it delivers in industries such as healthcare, life sciences, and food and beverage. The partnership’s emphasis on storytelling and community-generated content allows viewers to connect with the technology on a deeper level, fostering understanding and inspiring innovation.

Phononic’s collaboration with MarketScale as their video production and community-generated content creation partner reinforces their commitment to delivering impactful and engaging content. Through their combined expertise, they empower audiences to discover the immense potential and transformative capabilities of solid-state cooling and heating solutions.

Phononic

Part of this channel

Phononic

Solid-state cooling without compressors, refrigerants, or trade-offs.

Visit the channel

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Roche pTau217 clearance and Labcorp’s Alzheimer’s test bring diagnostics to primary care

Roche pTau217 clearance and Labcorp’s Alzheimer’s test bring diagnostics to primary care

Recent advancements in Alzheimer’s pathology tests and lab automation are transforming diagnostics by moving the bottleneck from assay availability to workflow activation. These developments are making it feasible for primary care facilities to access cutting-edge diagnostic tools. This shift promises to enhance early detection and treatment strategies for Alzheimer's disease.

  • 01Lab automation is helping to remove bottlenecks in workflow activation for Alzheimer’s diagnostics.
  • 02Primary care facilities are gaining access to advanced Alzheimer’s diagnostic tests.
  • 03Early detection and treatment of Alzheimer's disease could be improved by these new diagnostic tools.

Aug 28, 2026

Genentech’s $750M Hillsboro build adds device fill-finish capacity by 2031

Genentech’s $750M Hillsboro build adds device fill-finish capacity by 2031

Genentech is investing $750 million in a new fill-finish plant in Hillsboro. The facility will focus on the production of prefilled syringes and autoinjectors. The site is expected to become operational in 2031.

  • 01Genentech is investing $750 million in a new Hillsboro facility.
  • 02The facility will produce prefilled syringes and autoinjectors.
  • 03Operations at the plant are expected to begin in 2031.

Aug 27, 2026

4basebio hpDNA in Genezen projects could cut AAV input DNA by 30%

4basebio hpDNA in Genezen projects could cut AAV input DNA by 30%

4basebio's cell-free hpDNA will be used by Genezen as starting material for viral vectors, potentially reducing the need for AAV input DNA by 30%. This innovation may lead to changes in the specification of plasmids and project timelines in gene therapy programs.

  • 01Genezen will utilize 4basebio’s cell-free hpDNA for viral vector production.
  • 02This approach could reduce AAV input DNA requirements by 30%.
  • 03The adoption of hpDNA could lead to changes in plasmid specification and project timelines.

Aug 27, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512